Cargando…
Inflammation-related signature for prognostic prediction, tumor immune, genomic heterogeneity, and drug choices in prostate cancer: Integrated analysis of bulk and single-cell RNA-sequencing
BACKGROUND: Prostate cancer (PCa) ranks as the second most prevalent malignancy among males on a global scale. Accumulating evidence suggests that inflammation has an intricate relationship with tumorigenesis, tumor progression and tumor immune microenvironment. However, the overall impact of inflam...
Autores principales: | Zhu, Weian, Huang, Jiongduan, Wu, Jianjie, Wu, Chenglun, Ye, Fengxi, Li, Xiang, Lai, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618505/ https://www.ncbi.nlm.nih.gov/pubmed/37920511 http://dx.doi.org/10.1016/j.heliyon.2023.e21174 |
Ejemplares similares
-
Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023) -
Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023) -
Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer
por: Liu, Wen, et al.
Publicado: (2023) -
Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma
por: Huang, Zhihong, et al.
Publicado: (2022) -
Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature
por: Wu, Yunhao, et al.
Publicado: (2023)